alexa Target Raf/MEK/ERK Kinase Cascade For Cancer Therapy
ISSN: 2169-0138

Drug Designing: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th Annual Congress on Drug Discovery & Designing
July 03-04, 2017 Bangkok, Thailand

Jiancheng Hu
Duke-NUS Medical School, Singapore
ScientificTracks Abstracts: Drug Des
DOI: 10.4172/2169-0138-C1-013
Abstract
Ras/Raf/MEK/ERK signaling plays a critical role in cell proliferation, differentiation and survival. Its dysfunction leads to developmental diseases and cancers. Recent studies have shown that hyperactive Ras/Raf/MEK/ERK signaling exists in >40% human cancers, which functions as a driver therapy, both Raf and MEK inhibitors have been developed and applied to clinical treatment. Although these inhibitors achieved a good efficacy in the short-term treatment of some BRAF (V600E)- positive cancers, cancers with genetic alterations on Ras or upstream exhibit intrinsic resistance to Raf/MEK inhibitors, appealing a complete understanding of molecular mechanisms that control Raf/MEK/ERK kinase cascade. In current studies, we employed molecular biology, biochemistry, cell biology and tumor xenograft model to dissect molecular details by which Raf kinase activates MEK and in turn MEK triggers ERK under both normal and pathological conditions. Our findings provided a novel target for the design of next generation of Raf/MEK inhibitors.
Biography

Jiancheng Hu has received his PhD from University of Colorado Denver in 2007. He has then worked at Washington University in St. Louis and Howard Hughes Medical Institute as a Post-doctoral Research Fellow. In 2014, he has joined National Cancer Centre Singapore where he has served as the Principal Investigator at the Laboratory of Cancer Signaling. Currently, he is an Assistant Professor in Cancer and Stem Cell Program, Duke-NUS Medical School, National University of Singapore. His research interests include the regulatory mechanism of Raf kinase and other oncogenic protein kinases under normal/pathological conditions, molecular basis that underlie intrinsic and acquired resistance of kinase inhibitors in clinic treatment of cancers and the development of novel kinase inhibitors.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords